Tuesday, July 28th, 2020 - WISEGUY RESEARCH CONSULTANTS PVT LTD

Global Covid-19 Vaccine Industry

New Study Reports “Covid-19 Vaccine Market 2020 Global Market Opportunities, Challenges, Strategies and Forecasts 2026” has been Added on WiseGuyReports.

Overview

The Global Covid-19 Vaccine Market report offers an unbiased analysis by acquiring raw data from private and public databases, archives, and other trustworthy sources. It offers predictions and foresights for the period of 2020 to 2026. The market variables shape the overall landscape with special emphasis on novel trends and emerging opportunities. The market gauges its prospects per region and country to further validate its claims. Prominent players in the industry are profiled and their strategies evaluated for better understanding.

This report focuses on the global Covid-19 Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Covid-19 Vaccine development in North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America.

The key players covered in this study
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Zydus Cadila
Moderna, Inc.
Curevac
ImmunoPrecise

Try Free Sample of Global Covid-19 Vaccine Market @   https://www.wiseguyreports.com/sample-request/5155348-global-covid-19-vaccine-market-size-status-and-forecast-2020-2026

Competition Landscape

The competition is analyzed with regards to the concentration of players. The Global Covid-19 Vaccine Market trends and patterns are studied and strategies formulated to navigate through various obstacles and unforeseen circumstances. Expansions, agreements, partnerships, mergers, acquisitions, and collaborations are strategies considered by the players to stay afloat in the industry. Range of products are benchmarked and sized according to features, consumer demand, and price.

Market segment by Type, the product can be split into
DNA
Live Attenuated Virus
NonReplicating Viral Vecto
Protein Subunit
RNA
Market segment by Application, split into
Treatment
Prevention

Method of Research

The study of the Global Covid-19 Vaccine Market aims to offer the latest and broadly covered information and for this, our deemed experts have employed the best methods possible, namely the parameters belonging to the Porter’s Five Force Model. The latest inputs have been gathered based on the latest and popular trends and also the names of the key contenders in the market and their extensive chain networks across the globe. Moreover, this section gives an insight into the parent industry, other than the macro-economic aspects and the main governing factors, in terms of the market segmentation. The market research has been extensively carried out by the experts using two effective methods, which are primary and secondary. Both these methods have aided the experts in providing our clients with the best knowledge of the Global Covid-19 Vaccine Market, while focusing on the shortcomings, threats, opportunities and the strengths of the overall market. 

Segmentation

The segments and sub-segments within the Covid-19 Vaccine report are highlighted and expounded in detail with value and growth revenue predictions. The estimations are gained from a SWOT analysis conducted by research analysts and based on the demand-supply chain, consumer sentiment, brand acceptance, and socio-economic factors. Government policies and their impact on the segments are taken into consideration.

Report covers:

  • Comprehensive research methodology of Global Covid-19 Vaccine Market.
  • This report also includes detailed and extensive market overview with gap analysis, historical analysis & key analyst insights.
  • An exhaustive analy sis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Covid-19 Vaccine Market.
  • Insights about market determinants which are stimulating the Global Covid-19 Vaccine Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues
  • Extensive profiles and recent developments of market players

If you have any enquiry before buying a copy of this report @ https://www.wiseguyreports.com/enquiry/5155348-global-covid-19-vaccine-market-size-status-and-forecast-2020-2026

 Some points from table of content:

1 Report Overview
2 Global Growth Trends by Regions
3 Competition Landscape by Key Players
4 Breakdown Data by Type (2015-2026)
5 Covid-19 Vaccine Breakdown Data by Application (2015-2026)
6 North America
7 Europe
8 China
9 Japan
10 South Korea
11 Middle East
12 Southeast Asia
13 Central & South America
14 Key Players Profiles
14.1 Inovio Pharmaceuticals
14.1.1 Inovio Pharmaceuticals Company Details
14.1.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
14.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
14.1.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020))
14.1.5 Inovio Pharmaceuticals Recent Development
14.2 Takis Biotech (Evvivax)
14.2.1 Takis Biotech (Evvivax) Company Details
14.2.2 Takis Biotech (Evvivax) Business Overview and Its Total Revenue
14.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Introduction
14.2.4 Takis Biotech (Evvivax) Revenue in Covid-19 Vaccine Business (2015-2020)
14.2.5 Takis Biotech (Evvivax) Recent Development
14.3 Zydus Cadila
14.3.1 Zydus Cadila Company Details
14.3.2 Zydus Cadila Business Overview and Its Total Revenue
14.3.3 Zydus Cadila Covid-19 Vaccine Introduction
14.3.4 Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020)
14.3.5 Zydus Cadila Recent Development
14.4 Codagenix, Inc.
14.4.1 Codagenix, Inc. Company Details
14.4.2 Codagenix, Inc. Business Overview and Its Total Revenue
14.4.3 Codagenix, Inc. Covid-19 Vaccine Introduction
14.4.4 Codagenix, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
14.4.5 Codagenix, Inc. Recent Development
14.5 GeoVax, Inc.
14.5.1 GeoVax, Inc. Company Details
14.5.2 GeoVax, Inc. Business Overview and Its Total Revenue
14.5.3 GeoVax, Inc. Covid-19 Vaccine Introduction
14.5.4 GeoVax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
14.5.5 GeoVax, Inc. Recent Development
14.6 Bravovax
14.6.1 Bravovax Company Details
14.6.2 Bravovax Business Overview and Its Total Revenue
14.6.3 Bravovax Covid-19 Vaccine Introduction
14.6.4 Bravovax Revenue in Covid-19 Vaccine Business (2015-2020)
14.6.5 Bravovax Recent Development
14.7 Janssen Pharmaceutical Companies
14.7.1 Janssen Pharmaceutical Companies Company Details
14.7.2 Janssen Pharmaceutical Companies Business Overview and Its Total Revenue
14.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Introduction
14.7.4 Janssen Pharmaceutical Companies Revenue in Covid-19 Vaccine Business (2015-2020)
14.7.5 Janssen Pharmaceutical Companies Recent Development
14.8 Altimmune
14.8.1 Altimmune Company Details
14.8.2 Altimmune Business Overview and Its Total Revenue
14.8.3 Altimmune Covid-19 Vaccine Introduction
14.8.4 Altimmune Revenue in Covid-19 Vaccine Business (2015-2020)
14.8.5 Altimmune Recent Development
14.9 Vaxart
14.9.1 Vaxart Company Details
14.9.2 Vaxart Business Overview and Its Total Revenue
14.9.3 Vaxart Covid-19 Vaccine Introduction
14.9.4 Vaxart Revenue in Covid-19 Vaccine Business (2015-2020)
14.9.5 Vaxart Recent Development
14.10 CanSino Biologics
14.10.1 CanSino Biologics Company Details
14.10.2 CanSino Biologics Business Overview and Its Total Revenue
14.10.3 CanSino Biologics Covid-19 Vaccine Introduction
14.10.4 CanSino Biologics Revenue in Covid-19 Vaccine Business (2015-2020)
14.10.5 CanSino Biologics Recent Development
14.11 ExpreS2ion Biotechnologies ApS
10.11.1 ExpreS2ion Biotechnologies ApS Company Details
10.11.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue
10.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Introduction
10.11.4 ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Vaccine Business (2015-2020)
10.11.5 ExpreS2ion Biotechnologies ApS Recent Development
14.12 Clover Biopharmaceuticals
10.12.1 Clover Biopharmaceuticals Company Details
10.12.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue
10.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Introduction
10.12.4 Clover Biopharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020)
10.12.5 Clover Biopharmaceuticals Recent Development
14.13 GSK
10.13.1 GSK Company Details
10.13.2 GSK Business Overview and Its Total Revenue
10.13.3 GSK Covid-19 Vaccine Introduction
10.13.4 GSK Revenue in Covid-19 Vaccine Business (2015-2020)
10.13.5 GSK Recent Development
14.14 Vaxil Bio Ltd.
10.14.1 Vaxil Bio Ltd. Company Details
10.14.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue
10.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Introduction
10.14.4 Vaxil Bio Ltd. Revenue in Covid-19 Vaccine Business (2015-2020)
10.14.5 Vaxil Bio Ltd. Recent Development
14.15 Generex
10.15.1 Generex Company Details
10.15.2 Generex Business Overview and Its Total Revenue
10.15.3 Generex Covid-19 Vaccine Introduction
10.15.4 Generex Revenue in Covid-19 Vaccine Business (2015-2020)
10.15.5 Generex Recent Development
14.16 Novavax, Inc.
10.16.1 Novavax, Inc. Company Details
10.16.2 Novavax, Inc. Business Overview and Its Total Revenue
10.16.3 Novavax, Inc. Covid-19 Vaccine Introduction
10.16.4 Novavax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
10.16.5 Novavax, Inc. Recent Development
14.17 Sanofi Pasteur
10.17.1 Sanofi Pasteur Company Details
10.17.2 Sanofi Pasteur Business Overview and Its Total Revenue
10.17.3 Sanofi Pasteur Covid-19 Vaccine Introduction
10.17.4 Sanofi Pasteur Revenue in Covid-19 Vaccine Business (2015-2020)
10.17.5 Sanofi Pasteur Recent Development
14.18 Baylor
10.18.1 Baylor Company Details
10.18.2 Baylor Business Overview and Its Total Revenue
10.18.3 Baylor Covid-19 Vaccine Introduction
10.18.4 Baylor Revenue in Covid-19 Vaccine Business (2015-2020)
10.18.5 Baylor Recent Development
14.19 iBio, Inc.
10.19.1 iBio, Inc. Company Details
10.19.2 iBio, Inc. Business Overview and Its Total Revenue
10.19.3 iBio, Inc. Covid-19 Vaccine Introduction
10.19.4 iBio, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
10.19.5 iBio, Inc. Recent Development
14.20 Zydus Cadila
10.20.1 Zydus Cadila Company Details
10.20.2 Zydus Cadila Business Overview and Its Total Revenue
10.20.3 Zydus Cadila Covid-19 Vaccine Introduction
10.20.4 Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020)
10.20.5 Zydus Cadila Recent Development
14.21 Moderna, Inc.
10.21.1 Moderna, Inc. Company Details
10.21.2 Moderna, Inc. Business Overview and Its Total Revenue
10.21.3 Moderna, Inc. Covid-19 Vaccine Introduction
10.21.4 Moderna, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
10.21.5 Moderna, Inc. Recent Development
14.22 Curevac
10.22.1 Curevac Company Details
10.22.2 Curevac Business Overview and Its Total Revenue
10.22.3 Curevac Covid-19 Vaccine Introduction
10.22.4 Curevac Revenue in Covid-19 Vaccine Business (2015-2020)
10.22.5 Curevac Recent Development
14.23 ImmunoPrecise
10.23.1 ImmunoPrecise Company Details
10.23.2 ImmunoPrecise Business Overview and Its Total Revenue
10.23.3 ImmunoPrecise Covid-19 Vaccine Introduction
10.23.4 ImmunoPrecise Revenue in Covid-19 Vaccine Business (2015-2020)
10.23.5 ImmunoPrecise Recent Development
15 Analyst's Viewpoints/Conclusions
16 Appendix

For more information or any query mail at [email protected]

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

NOTE : Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact Profile

WISEGUY RESEARCH CONSULTANTS PVT LTD


Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.


Saurabh Sinha
W: www.wiseguyreports.com/

Keywords

wiseguyreports.com Adds “Covid-19 Vaccine Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2026” To Its Research Database

Categories

Sharing

More Formats